Replies to post #4010 on Antares Pharma, Inc. (ATRS)

[Bio_pete]

This quarter is going to look bad in comparison to the 2nd qtr 2015 since they only lost $1.5 million in the qtr. Net incomes been trending in the wrong direction.

I'll guess $7M on the cash burn since R&D should be down $500 million from the previous qtr. SG&A - I'll go with your number $7.5M.

They need to hang a "For Sale" sign on the door.